Skip to main content

Table 1 Demographic and clinical characteristics of 972 UC cases and 1098 controls

From: The association between metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study in China

Variables

Controls, n (%)

UC cases, n (%)

P value

Age, years

  

0.559

 <45

111 (10.1)

86 (8.8)

 

 45-

196 (17.9)

159 (16.4)

 

 55-

314 (28.6)

289 (29.7)

 

 ≥65

477 (43.4)

438 (45.1)

 

 Median (IQR)

62 (19)

63 (20)

 

Gender

  

0.906

 Male

914 (83.2)

811 (83.4)

 

 Female

184 (16.8)

161 (16.6)

 

BMI, kg/m2

  

0.425

 <25

610 (55.6)

523 (53.8)

 

 ≥25

488 (44.4)

449 (46.2)

 

Smoking status

  

0.005

 No

697 (63.5)

558 (57.4)

 

 Ever/current

401 (36.5)

414 (42.6)

 

Alcohol consumption

  

0.861

 No

745 (67.9)

656 (67.5)

 

 Yes

353 (32.1)

316 (32.5)

 

Hypertension

  

0.506

 No

775 (70.6)

673 (69.2)

 

 Yes

323 (29.4)

299 (30.8)

 

Diabetes mellitus

  

0.008

 No

903 (82.2)

754 (77.6)

 

 Yes

195 (17.8)

218 (22.4)

 

Lipid profiles, mg/dL

   

 Triglycerides

  

0.033

  Normal (<150)

852 (77.6)

715 (73.6)

 

  Abnormal(≥150)

246 (22.4)

257 (26.4)

 

 HDL

  

0.158

  Normal(≥40)

890 (81.1)

811 (83.4)

 

  Abnormal(<40)

208 (18.9)

161 (16.6)

 

MetS

  

0.080

 No

938 (85.4)

803 (82.6)

 

 Yes

160 (14.6)

169 (17.4)

 

Stage at diagnosis

   

 Ta

 

567 (58.4)

 

 T1

 

220 (22.6)

 

 T2

 

98 (10.1)

 

 T3

 

57 (5.9)

 

 T4

 

16 (1.6)

 

 Tis

 

14 (1.4)

 

Pathology grade

   

 Papilloma

 

60 (6.2)

 

 LGMPUP

 

19 (2)

 

 LGPUC

 

421 (43.4)

 

 HGPUC

 

472 (48.6)

 
  1. a UC urothelial carcinoma of bladder; BMI body mass index; LGMPUP low-grade malignant papillary urothelial papilloma; LGPUC low-grade papillary urothelial carcinoma; HGPUC high-grade papillary urothelial carcinoma